From the paper they are actually planning on trying this within a Fortune 100 company so this at least must be allowable.
To that end, we have reached an agreement with a Fortune 100 company to demonstrate the value of our tool as part of their COVID-19 management practices. As we have shown there are cultural and age differences in coughs, future work could focus on tailoring the model to different age groups and regions of the world using the metadata captured, something we would like to test at the company site.
From the paper they are actually planning on trying this within a Fortune 100 company so this at least must be allowable.